6.9018
price down icon3.47%   -0.2482
after-market Dopo l'orario di chiusura: 7.03 0.1282 +1.86%
loading

Lyra Therapeutics Inc Borsa (LYRA) Ultime notizie

pulisher
11:35 AM

Short interest data insights for Lyra Therapeutics Inc.July 2025 WrapUp & Daily Volume Surge Trade Alerts - newser.com

11:35 AM
pulisher
09:03 AM

Is Lyra Therapeutics Inc. stock supported by strong cash flowsMarket Sentiment Summary & Weekly High Momentum Picks - Trung tâm Dự báo KTTV quốc gia

09:03 AM
pulisher
Oct 13, 2025

What valuation multiples suggest for Lyra Therapeutics Inc. stock2025 Key Highlights & Risk Controlled Stock Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Using data models to predict Lyra Therapeutics Inc. stock movementTreasury Yields & Daily Oversold Stock Bounce Ideas - newser.com

Oct 13, 2025
pulisher
Oct 10, 2025

Regression analysis insights on Lyra Therapeutics Inc. performanceWeekly Market Report & Safe Capital Growth Tips - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Published on: 2025-10-09 05:19:19 - newser.com

Oct 09, 2025
pulisher
Oct 07, 2025

Lyra Therapeutics Announces Clinical Plan for LYR-210 and Late-Breaking Oral Presentation of Phase 3 ENLIGHTEN 2 Study - Sahm

Oct 07, 2025
pulisher
Oct 06, 2025

Lyra Therapeutics To Conduct One More Trial For Chronic Rhinosinusitis Treatment Candidate - Stocktwits

Oct 06, 2025
pulisher
Oct 06, 2025

Lyra Therapeutics Announces Clinical Plan for LYR-210 and - GlobeNewswire

Oct 06, 2025
pulisher
Oct 06, 2025

Lyra Therapeutics outlines path to NDA for CRS treatment - Investing.com

Oct 06, 2025
pulisher
Oct 06, 2025

Lyra Therapeutics (LYRA) Advances CRS Treatment with Positive Tr - GuruFocus

Oct 06, 2025
pulisher
Oct 06, 2025

Lyra Therapeutics outlines path to NDA for CRS treatment By Investing.com - Investing.com Australia

Oct 06, 2025
pulisher
Oct 06, 2025

Lyra unveils clinical plan for LYR-210, to present late-stage sinusitis trial data - MarketScreener

Oct 06, 2025
pulisher
Oct 06, 2025

Lyra Therapeutics Announces Clinical Plan for LYR-210 Following Positive ENLIGHTEN 2 Results and Upcoming FDA Engagement - Quiver Quantitative

Oct 06, 2025
pulisher
Oct 06, 2025

Lyra Therapeutics, Inc. Announces Clinical Plan for Lyr-210 and Late-Breaking Oral Presentation of Phase 3 Enlighten 2 Study - MarketScreener

Oct 06, 2025
pulisher
Oct 06, 2025

Multi asset correlation models including Lyra Therapeutics Inc.Weekly Profit Analysis & AI Powered Market Entry Strategies - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

What the charts say about Lyra Therapeutics Inc. todayJuly 2025 Selloffs & Intraday High Probability Setup Alerts - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Using Python tools to backtest Lyra Therapeutics Inc. strategiesMarket Volume Summary & Real-Time Volume Triggers - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

What analysts say about Lyra Therapeutics Inc stockRisk Adjusted Returns & Free Stock Price Trend Analysis - earlytimes.in

Oct 04, 2025
pulisher
Oct 03, 2025

Is Lyra Therapeutics Inc. stock ready for a breakoutPrice Action & Growth Focused Investment Plans - newser.com

Oct 03, 2025
pulisher
Oct 01, 2025

Goldman Sachs Group Inc. Sells 185,314 Shares of Lyra Therapeutics, Inc. $LYRA - Defense World

Oct 01, 2025
pulisher
Oct 01, 2025

Lyra Therapeutics (NASDAQ:LYRA) Stock Price Up 0.5% – Here’s Why - Defense World

Oct 01, 2025
pulisher
Sep 28, 2025

Is Lyra Therapeutics Inc a good long term investmentUtilities Sector Analysis & Target Triple-Digit Stock Opportunities - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

What drives Lyra Therapeutics Inc stock priceEarnings Miss Alerts & Capital Allocation Recommendations - earlytimes.in

Sep 28, 2025
pulisher
Sep 20, 2025

US Market Recap: How much upside does Lyra Therapeutics Inc haveGDP Growth & Trade Opportunity Analysis - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

Tech Rally: Is Lyra Therapeutics Inc stock a good pick for beginnersMarket Performance Report & Verified Technical Signals - khodrobank.com

Sep 20, 2025
pulisher
Sep 19, 2025

Quantitative breakdown of Lyra Therapeutics Inc. recent moveJuly 2025 Closing Moves & High Accuracy Swing Entry Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Market Moves: Should I hold or sell Lyra Therapeutics Inc nowEarnings Summary Report & Low Risk High Reward Trade Ideas - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Live market analysis of Lyra Therapeutics Inc.July 2025 Earnings & Risk Adjusted Buy and Sell Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Top chart patterns to watch in Lyra Therapeutics Inc.IPO Watch & Safe Capital Growth Trade Ideas - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Can swing trading help recover from Lyra Therapeutics Inc. lossesBull Run & Technical Entry and Exit Alerts - newser.com

Sep 19, 2025
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
Capitalizzazione:     |  Volume (24 ore):